Vaxart price prediction

image

Vaxart Inc (NASDAQ:VXRT)

The 4 analysts offering 12-month price forecasts for Vaxart Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +179.26% increase from the last price of 3.76.


Will vaxart go up tomorrow?

Tomorrow’s movement Prediction of Vaxart, Inc. VXRT as on 26 May 2022 appears strongly Bullish. This stock started moving upwards as soon as it opened….Munafa value: 65 as on 26 Thu May 2022.Upside target3.59Upside target3.4Downside target3.31Downside target3.24Downside target3.214 more rows


Should I buy or sell vaxart?

4 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Vaxart in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Vaxart stock.


What is vaxart future?

Consensus from 5 of the American Biotechs analysts is that Vaxart is on the verge of breakeven. They anticipate the company to incur a final loss in 2023, before generating positive profits of US$25m in 2024. The company is therefore projected to breakeven around 2 years from today.


What is the price target for NIO?

Stock Price TargetsHigh$552.16Median$210.08Low$153.62Average$249.10Current Price$18.85


Should I hold vaxart?

Vaxart holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.


Is VXRT a good stock?

Out of 4 analysts, 3 (75%) are recommending VXRT as a Strong Buy, 0 (0%) are recommending VXRT as a Buy, 1 (25%) are recommending VXRT as a Hold, 0 (0%) are recommending VXRT as a Sell, and 0 (0%) are recommending VXRT as a Strong Sell. What is VXRT’s earnings growth forecast for 2022-2024?


Why is vaxart up today?

Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral coronavirus vaccine. As of 2:20 p.m. EDT, Vaxart’s stock price was up more than 12%.


Who is VXRT stock?

Performance OutlookPrevious Close3.5200Bid3.6100 x 3100Ask3.6700 x 3000Day’s Range3.3300 – 3.740052 Week Range2.4900 – 10.33003 more rows


Is vaxart publicly traded?

Our common stock is listed on the Nasdaq Capital Market under the symbol “VXRT.” On April 8, 2019, the last reported sale price of our common stock was $1.49 per share. There is no established public trading market for the pre-funded warrants and the common warrants, and we do not expect a market to develop.


What will NIO stock be in 2023?

Nio Stock ForecastYearLower RangeHigher Range2022$24.03$27.512023$32.44$37.142024$43.79$50.132025$59.11$67.685 more rows•May 30, 2022


What will NIO be worth 2022?

NIO Stock Price Forecast 2022-2023 The forecasted NIO price at the end of 2022 is $26.31 – and the year to year change -17%. The rise from today to year-end: +40%. In the middle of 2022, we expect to see $21.28 per 1 NIO.


Who owns the most NIO stock?

Baillie Gifford & Co.Top 10 Owners of NIO IncStockholderStakeShares ownedBaillie Gifford & Co.5.75%88,750,621BlackRock Fund Advisors2.57%39,711,343The Vanguard Group, Inc.2.47%38,187,213SSgA Funds Management, Inc.1.74%26,808,6436 more rows

Leave a Comment